Promoters hold 75.3% of Akums Drugs and Pharmaceuticals Limited (AKUMS). FIIs hold 1.9%, mutual funds 9.8% and other DIIs 3.7%. No promoter pledge is reported. Quarterly shareholding, quarter ended Jun 26.
Folio counts aren't part of the shareholding pattern we ingest today — they arrive with a later filing parse.
| Holder | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Aug 24 |
|---|---|---|---|---|---|---|---|---|---|
| Promoters | 75.3% | 75.3% | 75.3% | 75.3% | 75.3% | 75.3% | 75.3% | 75.3% | 75.3% |
| FII | 1.9% | 1.4% | 1.1% | 2.3% | 4.2% | 5.8% | 6.4% | 7.3% | 5.3% |
| MF | 9.8% | 10.9% | 11.2% | 6.4% | 6.7% | 6.1% | 5.5% | 5.2% | 3.1% |
| Other DII | 3.7% | 3.4% | 3.2% | 2.8% | 2.1% | 1.3% | 1.5% | 2.3% | 4.5% |
| Retail & others | 6.7% | 6.3% | 6.5% | 10.5% | 8.9% | 8.8% | 8.7% | 7.2% | 9.1% |
No bulk or block deals disclosed for this stock in the last 90 days.
Bulk deals are uncommon for large caps — a single client has to trade over 0.5% of the company's shares in one day. Most weeks, none happen.
In Jun 26, FII holding rose +0.5pp and mutual funds −1.2pp, while retail added +0.4pp. Falling institutional ownership can read as distribution — though institutions can be wrong, and it’s never a guarantee.
Quarterly shareholding patternas of Jun 26
